Business Description
Tianda Pharmaceuticals Ltd
ISIN : KYG887471038
Total Employee Number:
613Compare
Compare
Traded in other countries / regions
00455.Hong Kong IPO Date
1992-03-30Description
Tianda Pharmaceuticals Ltd is engaged in research and development, manufacturing, and sales of pharmaceutical, biotechnology, and healthcare products, and investment in the development of the Chinese medicine industry. The group also engages in research and development of Chinese medicine, sales of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicine, and provision of Chinese medicine clinical services. Its operating segments include the Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives the majority of its revenue from the Pharmaceuticals and medical technologies business. Its geographical segments include Mainland China, Hong Kong, and Australia.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | -2.31 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.45 | |||||
Beneish M-Score | -2.98 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.1 | |||||
3-Year EBITDA Growth Rate | -86.6 | |||||
3-Year EPS without NRI Growth Rate | -34.4 | |||||
3-Year FCF Growth Rate | 50.7 | |||||
3-Year Book Growth Rate | -15.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.19 | |||||
9-Day RSI | 49.93 | |||||
14-Day RSI | 53.07 | |||||
3-1 Month Momentum % | -1.1 | |||||
6-1 Month Momentum % | -23.73 | |||||
12-1 Month Momentum % | -52.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.68 | |||||
Quick Ratio | 0.48 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 90.45 | |||||
Days Sales Outstanding | 68.33 | |||||
Days Payable | 151.65 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.76 | |||||
Operating Margin % | -13.93 | |||||
Net Margin % | -19.69 | |||||
EBITDA Margin % | -17.92 | |||||
FCF Margin % | -1.88 | |||||
OCF Margin % | 4 | |||||
ROE % | -14.96 | |||||
ROA % | -9.12 | |||||
ROIC % | -7.14 | |||||
3-Year ROIIC % | 40.46 | |||||
ROC (Joel Greenblatt) % | -16.23 | |||||
ROCE % | -12.42 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.68 | |||||
PB Ratio | 0.54 | |||||
Price-to-Tangible-Book | 0.85 | |||||
Price-to-Operating-Cash-Flow | 18.5 | |||||
EV-to-EBIT | -5.39 | |||||
EV-to-EBITDA | -5.39 | |||||
EV-to-Revenue | 0.97 | |||||
EV-to-FCF | -51.49 | |||||
Price-to-GF-Value | 0.85 | |||||
Price-to-Median-PS-Value | 0.74 | |||||
Earnings Yield (Greenblatt) % | -18.55 | |||||
FCF Yield % | -2.76 | |||||
Forward Rate of Return (Yacktman) % | 32.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tianda Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 350.532 | ||
| EPS (TTM) (HK$) | -0.032 | ||
| Beta | 0.1379 | ||
| 3-Year Sharpe Ratio | -0.46 | ||
| 3-Year Sortino Ratio | -0.64 | ||
| Volatility % | 52.85 | ||
| 14-Day RSI | 53.07 | ||
| 14-Day ATR (HK$) | 0.006021 | ||
| 20-Day SMA (HK$) | 0.1087 | ||
| 12-1 Month Momentum % | -52.63 | ||
| 52-Week Range (HK$) | 0.081 - 0.194 | ||
| Shares Outstanding (Mil) | 2,150.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tianda Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tianda Pharmaceuticals Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tianda Pharmaceuticals Ltd Frequently Asked Questions
What is Tianda Pharmaceuticals Ltd(HKSE:00455)'s stock price today?
The current price of HKSE:00455 is HK$0.11. The 52 week high of HKSE:00455 is HK$0.19 and 52 week low is HK$0.08.
When is next earnings date of Tianda Pharmaceuticals Ltd(HKSE:00455)?
The next earnings date of Tianda Pharmaceuticals Ltd(HKSE:00455) is .
Does Tianda Pharmaceuticals Ltd(HKSE:00455) pay dividends? If so, how much?
Tianda Pharmaceuticals Ltd(HKSE:00455) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Tianda Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers